Testosterone is one of the most discussed and misunderstood tools in modern men’s health. On one hand, it is portrayed as a remedy for aging. On the other, its legitimate clinical value is frequently downplayed. The evidence suggests a more nuanced view: Testosterone replacement can be life-changing for appropriately diagnosed hypogonadism, while many broader benefits remain evolving or indirect.
The well-known benefits are in hormonal and sexual health. For men with symptomatic testosterone deficiency, replacement can restore testosterone levels and enhance libido, sexual activity, and certain aspects of erectile function. It can resolve otherwise unexplained anemia, boost lean body mass, and improve bone density as well as skeletal microarchitecture. Muscle mass increases more reliably than physical performance. However, the bone density improvements have not been proven to prevent fractures. These distinctions are important.
The next frontier is whole-person function. Low testosterone coexists with low energy, depressed mood, reduced confidence, decreased sexual interest, frailty, obesity, chronic disease, and relationship strain. Treatment may improve well-being or depression in selected men, but testosterone is not an antidepressant, relationship therapy, or social enhancer. When sexual function, vitality, mobility, and self-image improve together, relational and social gains may follow. These improvements are plausible and clinically relevant, but largely indirect.
Pain and substance misuse management present another evolving intersection. Prolonged opioid use can inhibit the hypothalamic-pituitary-gonadal axis, leading to androgen deficiency. Small studies indicate that testosterone replacement in affected men may improve body composition, sexual desire, and pain sensitivity, although improvement in clinical pain itself was inconsistent. Testosterone is not a treatment for substance misuse. Its potential role is limited: recognizing and treating endocrine issues that hinder recovery, function, and quality of life.
Real physician voices, twice a week
Join 100,000+ subscribers. Free, and one click to unsubscribe.
Research in metabolism is intriguing. Testosterone can decrease fat mass and increase lean mass in hypogonadal men. The T4DM trial found fewer cases of type 2 diabetes when testosterone was included in a lifestyle intervention for selected older men at high metabolic risk. This is significant, but has not made testosterone a standard diabetes-prevention treatment. Future studies may uncover metabolic profiles where hormonal restoration adds value to weight management, exercise, nutrition, and emerging anti-obesity therapies.
Cardiovascular research has progressed. The large TRAVERSE trial found that testosterone replacement was not inferior to placebo for major adverse cardiovascular events in selected men with hypogonadism and cardiovascular conditions. This result offers reassurance but does not permit indiscriminate prescribing. Testosterone can elevate blood pressure and hematocrit, and treatment still requires appropriate diagnosis and monitoring.
Sleep management warrants caution. Restoring normal testosterone levels may enhance energy and daytime function when deficiency contributes to symptoms. However, testosterone is not a sleep therapy and may worsen sleep-disordered breathing in susceptible men. Sleep apnea, obesity, medications, depression, and systemic diseases should be correctly identified as separate issues, not as “low T.”
The future of men’s health lies in precision medicine: Diagnose the cause of testosterone deficiency, differentiate reversible metabolic suppression from true gonadal disease, and integrate aspects of sexual, musculoskeletal, mental, sleep, metabolic, cardiovascular, and reproductive health. Indeed, it should measure outcomes that matter to patients. Biomarkers, digital phenotyping, body composition tracking, and personalized risk prediction may show who benefits most and who does not.
Testosterone should neither be feared nor idolized. Modern men’s health requires more than just hormone hype. It calls for precise diagnosis, evidence-based treatment, careful monitoring, and integrated care. The future is not higher testosterone at any cost. It is healthier men, treated more precisely.
Olumuyiwa Bamgbade is an accomplished health care leader with a strong focus on value-based health care delivery. A specialist physician with extensive training across Nigeria, the United Kingdom, the United States, and South Korea, Dr. Bamgbade brings a global perspective to clinical practice and health systems innovation.
He serves as an adjunct professor at academic institutions across Africa, Europe, and North America and has published 45 peer-reviewed scientific papers in PubMed-indexed journals. His global research collaborations span more than 20 countries, including Nigeria, Australia, Iran, Mozambique, Rwanda, Kenya, Armenia, South Africa, the U.K., China, Ethiopia, and the U.S.
Dr. Bamgbade is the director of Salem Pain Clinic in Surrey, British Columbia, Canada—a specialist and research-focused clinic. His work at the clinic centers on pain management, health equity, injury rehabilitation, neuropathy, insomnia, societal safety, substance misuse, medical sociology, public health, medicolegal science, and perioperative care.
